Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
FDA Approvals
New Long-Acting Insulin Degludec Lowers Hypoglycemia Significantly versus Insulin Glargine
Wayne Kuznar
Read More
FDA Approvals
The Ancient Anti-Inflammatory Drug Salsalate Lowers Blood Glucose Levels
Wayne Kuznar
Read More
FDA Approvals
Diabetes Drug Pipeline: Promising Agents in Late Stages of Development
Wayne Kuznar
Read More
Medical Spending for Diabetes, 1987-2008: Where Does the Money Go?
Mary Mosley
Read More
Head-to-Head Comparison: Early Insulin Glargine Can Help Achieve Glycemic Target in Type 2 Diabetes
Wayne Kuznar
Read More
Cardiometabolic Health
Glycemic Control in Patients with Type 2 Diabetes Significantly Lowers Cardiovascular Disease Risk
Wayne Kuznar
Read More
Early Intensive Therapy in Type 2 Diabetes Preserves Beta-Cell Function
Wayne Kuznar
Read More
Quality Improvement Programs Enhance Diabetes Care, Especially When Baseline Measures Are Poor
Wayne Kuznar
Read More
TODAY Study: New Data, Implications for Young Patients with Diabetes
Mary Mosley
Read More
1 in 4 Patients with Type 2 Diabetes Does Not Take Basal Insulin as Prescribed
Wayne Kuznar
Read More
191
192
193
194
195
196
197
Page 194 of 244
Results 1931 - 1940 of 2438